Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Chubb
Baxter
Accenture
US Department of Justice
Colorcon

Generated: August 22, 2019

DrugPatentWatch Database Preview

Claims for Patent: 5,034,428

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,034,428
Title: Immobilized biomolecules and method of making same
Abstract:A method of biomolecule immobilization is described in which the biomolecule itself or, alternatively, a monomer-conjugated biomolecule, is grafted with free monomer onto a hydrophilic, solid-phase, polymeric substrate which has been pre-irradiated with ionizing radiation. The pre-irradiation step is carried out, preferably at -78.degree. C. in air, while the grafting step is carried out at 0.degree. C. in a substantially oxygen-free atmosphere. The technique is applicable to immobilization of a wide variety of biomolecules, such as enzymes, catalysts, hormones, lectins, drugs, vitamins, antibodies, antigens, nucleic acids, DNA and RNA segments, pesticides, dyes and fertilizers. The products may be used for therapeutic or diagnostic applications or bioseparations.
Inventor(s): Hoffman; Allan S. (Seattle, WA), Dong; Liang C. (Seattle, WA)
Assignee: Board of Regents of the University of Washington (Seattle, WA)
Application Number:07/348,049
Patent Claims:1. A method of producing an immobilized biomolecule comprising the steps of:

exposing a solid-phase polymeric substrate to ionizing radiation at a temperature between about 0.degree. C. to about -78.degree. C.; and

contacting the irradiated substrate with a biomolecule and free monomer, in aqueous solution in a substantially oxygen-free atmosphere at a temperature less than the temperature at which the biomolecule inactivates, to form a graft copolymer, wherein the biomolecule is immobilized at least in part within the graft copolymer.

2. The method of claim 1 wherein the biomolecule is an enzyme.

3. The method of claim 2 wherein the enzyme is asparaginase.

4. The method of claim 1 wherein the biomolecule is a catalyst.

5. The method of claim 1 wherein the biomolecule is an antibody.

6. The method of claim 1 wherein the biomolecule is an antigen.

7. The method of claim 1 wherein the biomolecule is a drug.

8. The method of claim 1 wherein the biomolecule is a hormone.

9. The method of claim 1 wherein the biomolecule is a pesticide.

10. The method of claim 1 wherein the biomolecule is a fertilizer.

11. The method of claim 1 wherein the biomolecule is an insecticide.

12. The method of claim 1 wherein the biomolecule is a dye.

13. The method of claim 1 wherein the biomolecule is a vitamin.

14. The method of claim 1 wherein the biomolecule is a single or double stranded sequence of DNA or RNA.

15. The method of claim 1 wherein the biomolecule is a nucleic acid.

16. The method of claim 1 wherein the substrate is hydrophilic.

17. The method of claim 1 wherein the substrate is a polysaccharide.

18. The method of claim 1 wherein the substrate is selected from the group consisting of cellulose, agarose, sepharose and cross-linked dextran.

19. The method of claim 1 wherein the source of ionizing radiation is .sup.60 Co.

20. The method of claim 1 wherein the source of ionizing radiation is X-rays.

21. The method of claim 1 wherein the source of ionizing radiation is high-energy electrons.

22. The method of claim 1 wherein the source of ionizing radiation is radio frequency plasma gas discharge.

23. The method of claim 1 wherein a substrate is exposed to ionizing radiation at -78.degree. C.

24. The method of claim 1 wherein the monomer is characterized by having at least one vinyl group.

25. The method of claim 1 wherein the monomer is characterized by having at least one allyl group.

26. The method of claim 1 wherein the monomer is selected from the group shown in Table 1.

27. A method of producing an immobilized biomolecule comprising the steps of:

exposing a solid-phase polymeric substrate to ionizing radiation at a temperature between about 0.degree. C. to about -78.degree. C.; and

contacting the irradiated substrate with a monomer-conjugated biomolecule and free monomer, in aqueous solution in a substantially oxygen-free atmosphere at a temperature less than the temperature at which the biomolecule inactivates, to form a graft copolymer, wherein the biomolecule is immobilized at least in part within the graft copolymer.

28. The method of claim 27 wherein the biomolecule is an enzyme.

29. The method of claim 28 wherein the enzyme is asparginase.

30. The method of claim 27 wherein the biomolecule is a catalyst.

31. The method of claim 27 wherein the biomolecule is an antibody.

32. The method of claim 27 wherein the biomolecule is an antigen.

33. The method of claim 27 wherein the biomolecule is a drug.

34. The method of claim 27 wherein the biomolecule is a hormone.

35. The method of claim 27 wherein the biomolecule is a pesticide.

36. The method of claim 27 wherein the biomolecule is a fertilizer.

37. The method of claim 27 wherein the biomolecule is an insecticide.

38. The method of claim 27 wherein the biomolecule is a dye.

39. The method of claim 27 wherein the biomolecule is a vitamin.

40. The method of claim 27 wherein the biomolecule is a single or double stranded sequence of DNA or RNA.

41. The method of claim 27 wherein the biomolecule is a nucleic acid.

42. The method of claim 27 wherein the substrate is hydrophilic.

43. The method of claim 27 wherein the substrate is a polysaccharide.

44. The method of claim 27 wherein the substrate is selected from the group consisting of cellulose, agarose, sepharose and cross-linked dextran.

45. The method of claim 27 wherein the source of ionizing radiation is .sup.60 Co.

46. The method of claim 27 wherein the source of ionizing radiation is X-rays.

47. The method of claim 27 wherein the source of ionizing radiation is high-energy electrons.

48. The method of claim 27 wherein the source of ionizing radiation is a radio frequency plasma gas discharge.

49. The method of claim 27 wherein a substrate is exposed to ionizing radiation at -78.degree. C.

50. The method of claim 27 wherein the monomer is characterized by having at least one vinyl group.

51. The method of claim 27 wherein the monomer is characterized by having at least one allyl group.

52. The method of claim 278 wherein the monomer is selected from the group shown in Table 1.

Details for Patent 5,034,428

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Board of Regents of the University of Washington (Seattle, WA) 2008-07-23 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Deloitte
Fish and Richardson
Colorcon
AstraZeneca
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.